Tumor Suppressor FUS1 Signaling Pathway
Authors:
- Lin JiLJLin Ji
- Jack A. RothJRJack A. Roth
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (4) , 327-330
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Loss and Reduction of Fus1 Protein Expression is a Frequent Phenomenon in the Pathogenesis of Lung CancerClinical Cancer Research, 2008
- MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expressionProceedings of the National Academy of Sciences, 2007
- Predicting protein function from sequence and structureNature Reviews Molecular Cell Biology, 2007
- Enhancement of antitumor activity of cisplatin in human lung cancer cells by tumor suppressor FUS1Cancer Gene Therapy, 2007
- Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1Oncogene, 2007
- Autoimmunity, spontaneous tumourigenesis, and IL‐15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1The Journal of Pathology, 2007
- Structure of Apaf-1 in the Auto-Inhibited Form: A Critical Role for ADPCell Cycle, 2005
- Structure of the apoptotic protease-activating factor 1 bound to ADPNature, 2005
- Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivoCancer Gene Therapy, 2004
- Chromosome 3p and breast cancerJournal of Human Genetics, 2002